SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8304845
Source:
http://linkedlifedata.com/resource/pubmed/id/8304845
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0012634
,
umls-concept:C0021081
,
umls-concept:C0026609
,
umls-concept:C0039082
,
umls-concept:C0087111
,
umls-concept:C1516084
pubmed:issue
2
pubmed:dateCreated
1994-3-8
pubmed:abstractText
To determine if response to immunosuppressive treatment in motor neuron syndromes could be predicted on the basis of clinical features, anti-GM1 antibodies, or conduction block.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/M01-RR-00034
,
http://linkedlifedata.com/resource/pubmed/grant/M01-RR-01346
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8304845-7726976
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372436
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/G(M1) Ganglioside
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0003-9942
pubmed:author
pubmed-author:AmatoA AAA
,
pubmed-author:BarohnR JRJ
,
pubmed-author:JacksonC ECE
,
pubmed-author:KisselJ TJT
,
pubmed-author:LynnD JDJ
,
pubmed-author:MendellJ RJR
,
pubmed-author:RammohanK WKW
,
pubmed-author:SahenkZZ
,
pubmed-author:TanEE
,
pubmed-author:WarmoltsJ RJR
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
194-200
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:8304845-Adult
,
pubmed-meshheading:8304845-Aged
,
pubmed-meshheading:8304845-Amyotrophic Lateral Sclerosis
,
pubmed-meshheading:8304845-Cyclophosphamide
,
pubmed-meshheading:8304845-Female
,
pubmed-meshheading:8304845-G(M1) Ganglioside
,
pubmed-meshheading:8304845-Humans
,
pubmed-meshheading:8304845-Immunosuppressive Agents
,
pubmed-meshheading:8304845-Male
,
pubmed-meshheading:8304845-Middle Aged
,
pubmed-meshheading:8304845-Motor Neuron Disease
,
pubmed-meshheading:8304845-Neural Conduction
,
pubmed-meshheading:8304845-Prednisone
,
pubmed-meshheading:8304845-Prospective Studies
pubmed:year
1994
pubmed:articleTitle
Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder.
pubmed:affiliation
Department of Neurology, Ohio State University, Columbus.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't